3-Phosphoinositide-dependent protein kinase-1 (PDK1) is involved in numerous cellular responses. In this study, we investigated the protective effects of PDK1 gene expression against hypoxic conditions in cultured rat CMCs (rCMCs) and in a rat myocardial infarction (MI) model using the lentiviral vector (LeV) system. LeV-PDK1 transfer effectively reduced the apoptotic cell death caused by hypoxic injury as compared to LeV-GFP transfer in rCMCs the expression of survival proteins increased in the LeV-PDK1 group, whereas apoptosis signaling decreased in the rCMCs and in infarcted hearts treated with LeV-PDK1. LeV-PDK1 transfer also reduced apoptosis and infarct size and attenuated myocardial wall thinning and ventricular remodeling in a rat MI model. These findings suggest that PDK1 has a protective role in the injured ischemic myocardium via overexpression of the cell survival pathway in CMCs. Hence PDK1 can be used as a treatment strategy for myocardial salvage inin hypoxic injury.
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The prevalence of heart failure (HF) is increasing continuously worldwide, 1, 2) and myocardial infarction (MI) due to coronary atherosclerotic disease is one of the common causes of HF.
3) Cellular replacement of the infarcted myocardium is the best treatment for ischemic HF, theoretically. Despite various therapeutic advances in treating ischemic HF, an ideal treatment is far from being in use in clinical practice. [4] [5] [6] [7] [8] [9] [10] [11] The major reason for this is the limited regenerative power of adult cardiomyocytes (CMCs). [4] [5] [6] [7] [8] [9] [10] Severe ischemia or anoxia in the myocardium induces significant apoptosis or necrosis of CMCs via the activation of various kinds of death signals, which subsequently cause ventricular wall motion abnormalities, thinning, and ventricular remodeling. Hence the prevention or attenuation of these cell death processes is an important therapeutic goal in the amelioration of ventricular remodeling and HF progression. 12) Gene therapy has been proposed as an alternative strategy in restoring the function of the injured myocardium and in maintaining myocardial homeostasis in advanced ischemic HF. 13) This method provides a unique means of treating CMCs for which apoptosis or necrosis is imminent, especially due to hypoxia, with the goal of ameliorating HF progression. 12, 14, 15) 3-Phosphoinositide-dependent protein kinase-1 (PDK1) in complex with automatic gain control (AGC) kinase has been confirmed to be active in various cellular processes. PDK1 has been found to phosphorylate and activate various protein kinases, including protein kinase B, p70 ribosomal S6 kinase, protein kinase A, serum and glucocorticoid-induced kinase, and protein kinase C. 16, 17) It has also been found that the PDK1 pathway regulates diverse cellular processes, including cell survival and proliferation and metabolic pathways. [18] [19] [20] [21] [22] [23] [24] Thus inadequate regulation of AGC kinase members can induce or aggravate many diseases. A deficiency in AGC kinase activation might be a primary cause of the insulin-resistant form of diabetes, neuronal cell death following stroke, and heart failure. 25) On the other hand, hyperactivation of this pathway has been implicated in the induction of cardiac hypertrophy and in the survival and proliferation of a significant number of cancers, 26) but to date the role of PDK1 in MI has not been elucidated well.
In this study, in order to determine the exact role of PDK1 in MI, we used the lentiviral vector (LeV) system, a retroviral vector based on human immunodeficiency virus-1 (HIV-1), to deliver the PDK-1 gene to isolated rat CMCs (rCMCs) in vitro and to the tissue of a rat MI model in vivo.
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Materials and Methods
Preparation and concentration of DNA. For HIV-based LeV, we used a self-inactivating lentiviral transfer vector, RSV LTR-RREcPPT-CMV-GFP-PRE-SIN (RSV LTR, rous sarcoma virus and HIV chimeric long terminal repeat; RRE, HIV Rev response element; cPPT, HIV-1 central polypurine tract; CMV, human cytomegalovirus promoter; GFP, green fluorescent protein; PRE, human hepatitis virus post-transcriptional regulatory element; SIN, self-inactivating), which encodes the enhanced GFP gene driven by the CMV promoter. 27) To regulate lentivirus production, a LeV system was introduced into an expression cassette in order to use the vesicular stomatitis virus G envelope glycoprotein (VSV-G) to pseudo-type the lentivirus. [28] [29] [30] [31] To construct the complete LeV plasmid system, VSV-G, pMDL, and REV were produced. Further, LeV-PDK1 (the PDK1 gene containing LeV) was produced using the GFP expression cassette, and PDK1 cDNA (kindly donated by Professor Hyunjung Ha of Chungbuk National University, Cheongju, Korea) was inserted by restriction enzyme digestion in exchange for GFP. The various plasmid DNAs (PDK1, GFP, pMDL, VSV-G and REV) were mass produced in LB broth with transfected E. coli. DNA was extracted using a QIAGEN Ò Plasmid Mega kit (Qiagen, Hilden, Germany).
Lentiviral DNA production and concentration. HIV-based lentivirus stocks were generated by transient plasmid transfection into 293T cells, as described previously. 28, 32) The total DNA concentration was kept constant by including an LeV. And then 8 h 293T cells were transfected with plasmids by the calcium phosphate method, the medium was replaced, and 36 h post-transfection, the virus-containing medium was harvested, centrifuged (20,000 rpm, on 4 C for 2 h), and filtered through a 0.45-mm pore-size filter (Millipore, Billerica, MA). Infection unit (IU) level of LeV-DNA was determined with a fluorescence laser microscope (Olympus BX51, Tokyo), FACS, and by measuring the amount of p24 viral core antigen (GCRL, Korea).
Isolation and hypoxic injury of neonatal rat cardiomyocytes. Primary cultures of neonatal rCMCs were isolated from the hearts of 2 to 3-old rats (Sprague-Dawley, Orient Bio, Seongnam, Korea) by a modified protocol reported previously. [33] [34] [35] The hearts were then removed and the left ventricles harvested. The ventricles obtained were washed 3 times with cold ADS buffer in 116 mM NaCl, 20 mM HEPES, 0.8 mM NaH 2 PO 4 , 5.6 mM glucose, 5.4 mM KCl, 0.8 mM MgSO 4 , pH 7.4 (Sigma-Aldrich, St. Louis, MO), chopped, and digested 3 times for 20 min each with collagenase/pancreatin (0.56/0.3 mg/mL). The cells obtained were collected selectively and enriched by differential centrifugation through a discontinuous Percoll (GE Healthcare, Little Chalfont, UK) gradient at densities of 1.050, 1.062, and 1.082 g/mL. 36) The band at the 1.062/1.082 density interface was collected and used as the source of rCMCs. The rCMCs were then washed and suspended in Dulbecco's Modified Eagle's Medium (DMEM) (Gibco BRL, Rockville, MD) supplemented with medium 199 (M199), 10% horse serum, 5% fetal bovine serum, and 1% penicillin (10,000 units/mL)/ streptomycin (10,000 mg/mL), as previously described. [33] [34] [35] [36] Mononuclear cells (5 Â 10 5 cells/well) were seeded in 2% gelatin-coated 60 mm Primarian plastic culture six-well plate dishes (BD Biosciences, San Jose, CA). The medium was changed the following day with serum-free DMEM/M199 (4:1) medium. Neonatal rCMCs were incubated for 4 dat 37 C, 5% CO 2 and then exposured to hypoxic conditions.
To generate hypoxic conditions, cultured neonatal rCMCs were placed in a GasPakÔ pouch system (BD BBLÔ, BD Biosciences). After induction of hypoxic injury in a hypoxic chamber (1% O 2 ) for 12 h, rCMCs were infected with LeV-GFP or LeV-PDK1 evaluated for apoptosis by FACS analysis. For rCMCs/LeV-DNA infection (1:5 Â 10 7 IU), rCMCs were transiently transfected with Polybrane (4 mg/mL, Sigma-Aldrich) added to DMEM.
Infection with LeV-GFP and with PDK1. LeV-GFP (LeV containing the GFP gene) and LeV-PDK1 (LeV containing the PDK1 gene) were treated at 1:5 Â 10 7 IU in vitro and were injected directly at 5 Â 10 8 IU into the infarct border zone and the infarct zone of the left ventricular free wall (four sites, 50 mL/site) in vivo.
Assessment of apoptosis by flow cytometric analysis. Cultured neonatal rCMCs were stained with an Annexin V-Phycoerythrin (PE) kit (BD pharmingenÔ, BD Biosciences). An Annexin V-PE kit was used to assess the flip-flop of the cell membrane. 7-aminoacetinomycin D (7-AAD, BD PharmingenÔ, BD Biosciences) was used to assess cell membrane permeability and thus cell death. In brief, the collected rCMCs were washed twice with cold phosphate buffered saline (PBS) at pH 7.4 and then re-suspended in 1 Â Binding Buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl 2 , pH 7.4) at a concentration 5 Â 10 6 cells/mL. These mixtures were transferred to a 5 mL culture tube and 5 mL each of Annexin-V and 7-AAD were added. Gentle vortexing was done, and the rCMCs were incubated for 10 min at room temperature in the dark and analyzed by flow cytometry (FACS equipped with an argon ion laser, Ex 488 nm; Em 578 nm) using FACSCaliburÔ (BD Diagnostics, Oxnard, CA), and the percentages of positively stained cells were determined.
Detection of PDK1 expression. After induction of hypoxic injury in the hypoxic chamber (1% O 2 ) for 12 h, rCMCs infected with LeV-GFP or LeV-PDK1 were treated with B2311 (Sigma-Aldrich), and the expression of PDK1 was measured by Western blotting. B2311, 5-(2-benzothiazolyl)-3-ethyl-2-[2-(methylphenylamino) ethenyl]-1-phenyl-1H-benzimidazolium iodide, was used as an Akt IV inhibitor to determine whether PDK1 associates with Akt. B2311 is a cellpermeable benzimidazole compound that inhibits Akt phosphorylation/activation by targeting the ATP-binding site of a kinase upstream of Akt. 37) It was treated at a concentration of 1.0 mM/mL. To confirm infection by PDK1 of rCMCs, The expression of PDK1 was detected by immunocytochemistry. The rCMCs were incubated in the hypoxic chamber (1% O 2 ) for 12 h with LeV-PDK1 or LeV-GFP, followed by fixation using cold methanol. The rCMCs seeded on slide were subjected to immunocytochemistry at a 1:100 dilution of PDK1 antibody (Epitomics, Burlingame, CA) following the manufacturer's instructions using the VECTASTAIN avidin biotinylated enzyme complex kit (Vector Laboratories, Burlingame, CA).
Western blot analysis. Harvested cells and heart tissues were lysed with PRO-PREPÔ (iNtRON Biotechnology, Seongnam, Korea) and incubated at 4 C for 2 h. The extracts were then centrifuged at 12,000 rpm at 4 C for 15 min to remove insoluble material. Bradford assay was used for quantification. 38) Protein concentrations were determined by dye-binding assay using a Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA). Equal amounts of total protein (20 mg) were diluted with sample buffer containing 100 mM dithiothreitol and were heated 98 C for 5 min, and then they were subjected to 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) in a gel apparatus (Hoefer Scientific, San Francisco, CA), and subsequently transferred to PVDF membranes. The membranes were then blocked with 10% skim milk in TBS-T (TrisBuffered Saline, 0.2% Tween-20) for 2 h and then incubated with antibodies against PDK1 phospho-PDK1 (pPDK1, Epitomics, Burlingame, CA), Akt, phospho-Akt (pAkt), Bcl-2, Bax-, caspase-3, p53, GSK-3, phospho-GSK-3 (pGSK-3), and survivin (all Santa Cruz Biotechnology, Santa Cruz, CA). The antibodies were diluted 1:2,000 in TBS-T and incubated with the membranes with continuous shaking at room temperature for 1 h, followed by washing with TBS-T and incubation with horseradish peroxidase (HRP)-conjugated secondary antibody (1:2,000-1:5,000 dilution) for 1 h. Then the membranes were washed 3 times 10 min each in TBS-T. For detection, the membranes were saturated with WEST-ZOL Ò PLUS mixture (iNtRON Biotechnology) for 1 min, and chemiluminescence was viewed by autography using pre-flashed X-ray film (Fujifilm, Tokyo) for 10 to 300 s. Optical density was evaluated with the Multi Gauge Program (Fujifilm).
Generation of myocardial infarction and PDK1 gene transfer. Six-week-old Sprague-Dawley (SD) male rats were purchased from a commercial animal breeder (Orient Bio, Seongnam, Korea). Sixteen rats were acclimated for 1 week in an environmentally controlled room under 20 AE 2 C, relative humidity 50 AE 20%, and a 12 h light/dark cycle, and they were provided a commercial standard diet and water ad libitum. Each of the four rats was assigned to LeV-GFP or LeV-PDK1 myocardial injection after MI generation. All care and handling of the animals was done according to the ''Guide for the Care and Use of Laboratory Animals'' of Chungbuk National University, Korea (CBNUA-093-0906-01).
MI was induced in male SD rats (200-240 g) by a previously described method.
39) The rats were anesthetized with Zoletil Ò (50 mg/kg, Virbac, Carros, France) and Rompun Ò (10 mg/kg, Bayer, Leverkusen, Germany). The anesthetized rats were ventilated under positive pressure using a rodent ventilator (Model 683, Harvard Apparatus, South Natick, MA). Left thoracotomy was performed in the fourth intercostal space, and the pericardium was opened. The left anterior descending artery was suture-ligated with 6-0 silk. Then the LeV-GFP or LeV-PDK1 (5 Â 10 8 IU) was injected locally into the infarct and the infarct-border zone of the left ventricular myocardium in a total volume of 200 mL using an insulin syringe. The chest was then closed in layers and the pneumothorax evacuated.
Histopathological examination. At the end of the experimental period, the hearts were removed from the rats. The hearts were fixed in 10% formalin. They were embedded in paraffin, and 8-mm sections were stained with Hematoxylin-Eosin (H&E) and Masson's trichrome, subjected to immunohistochemistry (IHC; anti-PDK1, p53 and caspase-3), and observed by light microscopy (CX21 Binocular Microscope, Olympus, Hicksville, NY) TUNEL assay. A terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was performed using an Apop Tag Plus Peroxidase In situ Apoptosis Detection Kit following the recommendations of the manufacturer (Amersham Pharmacia Biotech, Piscataway, NJ). Briefly, sections were incubated with 15 g/mL of proteinase K for 15 min at room temperature and then washed in PBS. Endogenous peroxidase was quenched with 3% H 2 O 2 in distilled water for 15 min at room temperature. After washing in PBS, sections were immersed in buffer containing terminal deoxynucleotidyl transferase enzyme and incubated for 60 min at 37 C under a humid atmosphere. After a further washing in PBS, the sections were incubated with antidigoxigenin conjugate for 30 min at room temperature. Following additional washing in PBS, signals were detected using a VECTASTAIN Ò ABC Standard Elite Kit (Vector Laboratories, Burlingame, CA). After washing in PBS and development of color in peroxidase substrate with diaminobenzidine, the signals were examined by light microscopy.
Statistical analysis. Measurement data were expressed as mean AE standard deviation (SD). Comparisons between two groups were evaluated by t-test, and one-way ANOVA followed by post hoc Bonferroni's test was used for multiple group comparisons. Differences were considered statistically significant at p < 0:05 or 0.01.
Results

GFP expression in cardiomyocytes and myocardium
To evaluate the transfection efficacy of the LeV system, we used LeV-GFP as control and measured the expression of GFP. GFP expression was observed by fluorescence laser microscopy in the rCMCs. Furthermore, GFP expression was detected in the infarct-border zone in the LeV-GFP-injected (5 Â 10 8 IU) rat hearts. Since GFP was expressed in the transgene-positive cells, the expression of GFP in the rCMCs and the myocardium served as an indicator of successful gene transfection (Fig. 1) .
Enhancement of PDK1 expression by LeV-PDK1 in cardiomyocytes
To determine whether PDK1 gene transfection had been performed appropriately, we used Western blotting. LeV-PDK1 treatment effectively enhanced the expression of PDK1 and pPDK1 in the rCMCs, whereas simultaneous treatment with LeV-PDK1 and B2311 markedly reduced PDK1 and pPDK1 expression (Fig. 2) . Further, PDK1 overexpression in the rCMCs due to LeV-PDK1 delivery was confirmed by IHC (Fig. 3) . 
Flow cytometric analysis for hypoxically injured cardiomyocytes
In flow cytometric analysis using Annexin V-PE, the proportion of apoptotic cell death induced by hypoxia was significantly reduced by LeV-PDK1 transfection in the rCMCs (Fig. 4) .
Western blot analysis in vitro
LeV-PDK1 induced overexpression of cell survival signaling proteins and suppressed apoptotic signalrelated protein expression as compared to LeV-GFP and the control. In vitro, the expression levels of PDK1, pPDK1, pAkt/Akt, pGSK-3/GSK-3, survivin, and Bcl-2 were significantly enhanced by infection with LeV-PDK1 as measured by Western blot. However, the expression of Bax-, p53, and caspase-3 was reduced in the LeV-PDK1 group as compared to the LeV-GFP group (Fig. 5) . The optical density ratios of the analyzed proteins in LeV-GFP/rCMCs vs. LeV-PDK1/rCMCs were as follows: PDK1, 0:01 AE 0:01 vs. 14:58 AE 2:61; pPDK1, 0:05 AE 0:03 vs. The expression of cell survival-associated proteins such as PDK1, pPDK1, pGSK-3/GSK-3, and Bcl-2 was significantly enhanced in the LeV-PDK1/rCMCs as compared with the LeV-GFP/rCMCs, whereas the expression of Bax-and p53 fell in the LeV-PDK1/rCMCs. A, Western blot of LeV-GFP and LeV-PDK1-transfected rCMCs; B and C, densitometric analysis for quantification of blot (panel A).
Ã p < 0:05 and ÃÃ p < 0:01 as compared to LeV-GFP/rCMCs.
infarction as compared to LeV-GFP transfection in the rat MI model. The fibrosis area in the infarction zone too was more significantly reduced in the LeV-PDK1 than in the LeV-GFP group. Further, LeV-PDK1 transfection effectively limited ventricular wall thinning and preserved myocardial thickness in the infarction area as compared to LeV-GFP transfection ( Fig. 6 and Table 1 ).
Immunohistochemistry of PDK1, p53, and caspase-3
To evaluate the expression of cell survival-associated and anti-apoptotic signaling proteins in the myocardium, sectioned myocardial tissues were analyzed by IHC. PDK1 was significantly overexpressed in the LeV-PDK1 group as compared to the LeV-GFP group. The expression of p53 and caspase-3, which are associated with apoptosis, was significantly downregulated in the LeV-PDK1 group as compared to the LeV-GFP group (Fig. 7) .
TUNEL assay in the heart
As shown in Fig. 8 , LeV-PDK1 treatment significantly lessened the number of apoptotic cells as compared to the LeV-GFP-injected group. In the LeV-GFP group, apoptotic cells were occasionally observed in the infarct border zone and the infarct area, but they were more frequently found than in the LeV-PDK1 group (Fig. 8) . In a 400 Â magnified fields of view of the four locations, the average numbers of apoptotic cells were 23 and 9 in the LeV-GFP group and the LeV-PDK1 group respectively.
Discussion
Heart failure is one of the leading causes of morbidity and mortality worldwide, ischemic heart disease being the major problem. Despite the use of -blockers, aldosterone antagonists, and angiotensin-converting enzyme inhibitors, the 5-years survival rate of individuals with advanced ischemic HF is still less than 50%. 40) Recently, myocardial tissue replacement therapy using stem cells has emerged as a new option in the treatment of ischemic HF, but the effects of this therapy are very limited due to the disappointing regenerative power of the applied stem cells and their low level of successful implantation in infarcted myocardial tissue. [4] [5] [6] [7] [8] MI reduces the number of viable, functional CMCs, and this is the common path of progressive ventricular remodeling and HF generation. Hence a practical concern in ischemic HF treatment is to discover an appropriate way to decreasing apoptosis and necrosis of CMCs in an infarcted area. Considering the limited regenerative power of applied stem cells and resident cardiac stem cells, the ideal therapy would activate the survival mechanisms resulting from adaptation to ischemia.
The biological effects of PDK1, including cell survival and proliferation, and anti-apoptosis, in cancer tissues are well known, but the mechanism of PDK1 in MI has not been well elucidated. Moreover, the effects of PDK1 as to anti-apoptosis and cell survival signaling in CMCs remain to be identified. PDK1 is known to be a master kinase that mediates hormone and growth factorinduced activation of AGC kinases by phosphorylating these enzymes at their activation loop. 35, 41) In relation to cardiovascular disease, however, it is difficult to evaluate responses to PDK1 in vivo due to the lack of an appropriate PDK1 inhibitor. Hence we used the LeV system to strengthen the expression of PDK1 in order to study the role of PDK1 in a rat MI model. Studying PDK1 is more complicated than studying other kinases due to the absence of a specific inhibitor, 17) but we found that B2311 treatment decreased the expression of PDK1. Especially, expression of it fell more sharply in the LeV-PDK1 group than in the LeV-GFP group in rCMCs. This suggests that PDK1 expression is related to Akt signaling. Overexpression of PDK1 enhanced the expression of survival signaling proteins such as PDK1, pPDK1, pAkt/Akt, pGSK-3/GSK-3, survivin, and Bcl-2, whereas the expression of apoptotic molecules such as Bax, p53, and caspase-3 was attenuated. In flow cytometric analysis, apoptosis of CMCs declined significantly in the LeV-PDK1 group. These findings confirm that Akt activated by PDK1 overexpression improves the survival and function of CMCs in ischemic injury, but it is necessary that future studies determine the causal relationship between PDK1 expression and Akt expression.
The PI-3 Kinase/Akt pathway is a cell survival mechanism that attenuates apoptosis and regulates glycogen synthesis and glucose transport. The recovery of an ischemic heart is associated with phosphorylation and activation of Akt. 25, [35] [36] [37] 42) It was recently suggested that GSK mediates cardioprotection by phosphorylation of GSK-3. 43) This implies that a complete PDK1/Akt/ GSK-3 cascade is crucial to protect the myocardium from ischemia. Our results indicate that overexpression of PDK1 enhanced CMC survival under hypoxic conditions as compared to the control (LeV-GFP) group, and that the cardioprotective effect of the PDK1 gene was closely related with modification of cell survival signaling. We also found that overexpression of PDK1 by LeV-PDK1 can enhance survival signals in CMCs and attenuate the extent of fibrosis in cardiac remodeling. In an infarcted heart, prevention of CMC apoptosis, which can be followed by ischemic injury, is the most important therapeutic goal in limiting HF progression. Angiogenic and anti-apoptotic factor therapy of infarcted hearts were found to impede left ventricle remodeling and to preserve left ventricular functions in a series of studies. [44] [45] [46] Using LeV-PDK1 transfection, we significantly limited MI size, fibrosis area and ventricular myocardial mass reduction as compared to the LeV-GFP transfection group. In IHC, the expression of PDK1, p53, and caspase-3 appeared to be similar to the in vitro results. # p < 0:05 and ## p < 0:01 as compared to normal, Ã p < 0:05 and ÃÃ p < 0:01 as compared to LeV-GFP. Fig. 7 . Immunohistochemistry of PDK1, p53, and Caspase-3 in the Myocardium Tissue.
Normal heart (A), LeV-GFP-injected rat MI tissue (B), LeV-PDK1-injected rat MI tissue (C). IHC for PDK1 expression (A, B, and C-1), IHC for p53 expression (A, B, and C-2), IHC for caspase-3 expression (A, B, and C-3), arrowhead, strong expression; arrow, moderate expression; DAB staining and counter-stain with hematoxylin. Fig. 8 . TUNEL assay.
TUNEL assay was performed to determine the numbers of apoptotic cells in a normal heart (A), a LeV-GFP-injected heart (B), and a LeV-PDK1-injected heart (C). In the LeV-GFP-injected heart (B), TUNEL-positive apoptotic cells were more frequently found in the infarct area and border zone as compared with the heart injected with LeV-PDK1. A and D, Normal heart; B and E, LeV-GFP-injected heart; C and F, LeV-PDK1-injected heart (dark blue, nuclei; red, cytoplasm and muscle fiber; blue, collagen and fibrosis). In the left ventricle of the LeV-GFP-transfected group, aniline blue indicating myocardial infarction was more widely stained than the LeV-PDK1 group. LeV-PDK1 injection significantly limited the loss of left ventricular mass and thickness and effectively attenuated myocardial fibrosis as compared to LeV-GFP injection hearts.
## p < 0:01 as compared to normal heart, ÃÃ p < 0:01 as compared to LeV-GFP-injected heart.
Transfection of PDK1 suppressed apoptotic signaling molecules, e.g., p53 and caspase-3, in MI tissue. In the TUNEL assay, the numbers of apoptotic cells were lower in the LeV-PDK1 group.
In conclusion, PDK1 gene therapy prevented loss of CMCs via enhanced cell survival and anti-apoptotic signaling in a rat MI model. In this study, PDK1 overexpression induced by the LeV system improved ventricular remodeling and function. PDK1, Then, can be used as a treatment strategy for myocardial salvage at an early stage in hypoxic and ischemic injury.
